Edition:
United States

Camurus AB (CAMX.ST)

CAMX.ST on Stockholm Stock Exchange

113.80SEK
20 Apr 2018
Change (% chg)

-0.20kr (-0.18%)
Prev Close
114.00kr
Open
115.00kr
Day's High
115.00kr
Day's Low
113.40kr
Volume
41,434
Avg. Vol
39,994
52-wk High
147.80kr
52-wk Low
91.30kr

Chart for

About

Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)

Overall

Beta: --
Market Cap(Mil.): kr4,242.63
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  CAMX.ST Industry Sector
P/E (TTM): -- 31.01 33.60
EPS (TTM): -5.11 -- --
ROI: -40.15 13.60 13.19
ROE: -40.15 15.26 15.00

BRIEF-Camurus Q4 Operating Loss Widens To SEK ‍66.1​ Million

* Q4 NET SALES SEK ‍5.5​ MILLION VERSUS SEK 37.1 MILLION YEAR AGO

Feb 15 2018

BRIEF-Camurus AB Q4 Net Revenue Sek 5.5 Million Versus Sek 37.1 Million Year Ago

* Q4 NET REVENUE SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO

Feb 15 2018

BRIEF-Camurus Q3 operating loss widens to SEK ‍67.1​ million

* Q3 NET REVENUE SEK ‍12.5​ MILLION VERSUS SEK 30.5 MILLION YEAR AGO

Oct 26 2017

Earnings vs. Estimates